Onward Medical Bv Stock Gross Profit

63E Stock   4.42  0.04  0.90%   
ONWARD MEDICAL BV fundamentals help investors to digest information that contributes to ONWARD MEDICAL's financial success or failures. It also enables traders to predict the movement of ONWARD Stock. The fundamental analysis module provides a way to measure ONWARD MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ONWARD MEDICAL stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ONWARD MEDICAL BV Company Gross Profit Analysis

ONWARD MEDICAL's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current ONWARD MEDICAL Gross Profit

    
  (10.58 M)  
Most of ONWARD MEDICAL's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ONWARD MEDICAL BV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition
According to the company disclosure, ONWARD MEDICAL BV reported (10.58 Million) of gross profit. This is much lower than that of the sector and significantly lower than that of the Biotechnology industry. The gross profit for all Germany stocks is notably higher than that of the company.

ONWARD Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ONWARD MEDICAL's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ONWARD MEDICAL could also be used in its relative valuation, which is a method of valuing ONWARD MEDICAL by comparing valuation metrics of similar companies.
ONWARD MEDICAL is currently under evaluation in gross profit category among its peers.

ONWARD Fundamentals

About ONWARD MEDICAL Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ONWARD MEDICAL BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ONWARD MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ONWARD MEDICAL BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in ONWARD Stock

ONWARD MEDICAL financial ratios help investors to determine whether ONWARD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ONWARD with respect to the benefits of owning ONWARD MEDICAL security.